CD44 antibody flow cytometry — the immunophenotyping application using CD44 surface marker detection for cancer stem cell and immune cell analysis representing the dominant application segment in antibody-based research — creates the most clinically validated market segment, with the CD44 Antibody Market reflecting flow cytometry as the dominant commercial driver. The...